Mesa Labs Inc (MLAB) 112.17 $MLAB Mesa Labs Acquires

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 7:05 PM

Mesa Labs Inc (MLAB) 112.17 $MLAB

Mesa Labs Acquires Cold Chain Manufacturing Capabilities
GlobeNewswire - Wed Aug 10, 2:00PM CDT
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"

today announced the acquisition of certain assets and liabilities of Rapid Aid Corp ("Rapid Aid"

by the Company's subsidiary, Mesa Canada, Inc. ("Mesa Canada"

. Rapid Aid was the Company's exclusive supplier of cold chain packaging gel products ("CC Gels"

. The acquisition is expected to add approximately 550 basis points to Mesa's Cold Chain Packaging Division gross profit margin and to be neutral to our diluted net income per share ("EPS"

during the first 12 months.
MLAB: 112.17 (-1.21)

Allscripts Healthcare (MDRX) Posts In-Line Earnings in Q2
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 8:50AM CDT
Allscripts Healthcare reported second-quarter 2016 earnings of 10 cents per share, which was in line with the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), MDRX: 12.88 (-0.03), MLAB: 112.17 (-1.21)

Inogen (INGN) Beats Q2 Earnings & Revenues, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 2:43PM CDT
Inogen reported second-quarter 2016 earnings of 25 cents per share, which surpassed the Zacks Consensus Estimate by 6 cents.
MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), IDXX: 114.09 (+0.93), MLAB: 112.17 (-1.21)

Mesa Laboratories (MLAB) is Oversold: Can It Recover?
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:52AM CDT
Mesa Laboratories Inc. (MLAB) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
MLAB: 112.17 (-1.21)

TrovaGene (TROV) Loss Narrows Y/Y, Trovera Holds Promise
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 7:33AM CDT
TrovaGene Inc (TROV) reported loss of 34 cents per share in the second quarter of 2016, narrower than the year-ago loss of 41 cents.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), TROV: 4.96 (unch), MLAB: 112.17 (-1.21)

Pacific Biosciences (PACB) Q2 Impressive, View Encourages
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 6:45AM CDT
Pacific Biosciences of California Inc. (PACB) reported a loss of 21 cents per share, a penny narrower than the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), PACB: 8.28 (-0.02), MASI: 59.90 (+0.47), MLAB: 112.17 (-1.21)

Mazor Robotics (MZOR) Q2 Loss Narrower than Expected
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:19AM CDT
Mazor Robotics reported adjusted loss of 11 cents in the second quarter of 2016.
MASI: 59.90 (+0.47), MDT: 87.32 (+0.34), MZOR: 22.23 (+0.37), MLAB: 112.17 (-1.21)

Masimo (MASI) Beats Q2 Earnings, Revenues; FY16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:08AM CDT
Masimo Corp reported earnings of 49 cents per share that beat the Zacks Consensus Estimate by 8 cents.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16), MLAB: 112.17 (-1.21)

Exactech (EXAC) Beats Earnings on Higher Revenues in Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:25AM CDT
Exactech Inc. announced adjusted earnings of 31 cents per share in the second quarter of 2016.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EXAC: 27.90 (+0.10), MLAB: 112.17 (-1.21)

Luminex (LMNX) Gets FDA Nod for Assays; Q2 Earnings Beat
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:11AM CDT
Luminex reported second-quarter 2016 adjusted earnings of 26 cents per share, which surpassed the Zacks Consensus Estimate of 18 cents.
MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16), LMNX: 21.12 (+0.19), MLAB: 112.17 (-1.21)

CVS Health, Adapt Pharma Team Up to Discount NARCAN Price
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 5:38PM CDT
CVS Health and Adapt Pharma recently announced a partnership aimed at making the opioid overdose-reversing drug NARCAN Nasal Spray more affordable for patients without insurance coverage.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CVS: 93.84 (+0.47), MLAB: 112.17 (-1.21)

Cepheid (CPHD) Looks Good: Stock Adds 8% in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:25AM CDT
Cepheid (CPHD) moved big last session, as its shares jumped a little over 8% on the day.
CPHD: 34.42 (+0.16), MLAB: 112.17 (-1.21)

Mesa Labs Reports 16 Percent Increase in First Quarter Revenues
GlobeNewswire - Thu Jul 28, 7:02AM CDT
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company"

today reported a 16 percent increase in revenues for the first quarter ended June 30, 2016.
MLAB: 112.17 (-1.21)

Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 59.90 (+0.47), TMO: 151.18 (+0.23), CRY: 16.23 (+0.39), MLAB: 112.17 (-1.21)

IRadimed (IRMD) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:18AM CDT
On Jun 17, Zacks Investment Research raised IRadimed Corp. (IRMD) to a Zacks Rank #1 (Strong Buy).
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), MLAB: 112.17 (-1.21)

Can The Uptrend Continue for with Mesa Laboratories (MLAB)?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:51AM CDT
Investors certainly have to be happy with Mesa Laboratories Inc. (MLAB) and its short term performance
MLAB: 112.17 (-1.21)

Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: Apple Hospitality REIT, Coresite Realty, Brookfield CDA, Mesa Labs and Cryolife
APLE: 18.74 (-0.20), COR: 79.59 (+0.84), CRY: 16.23 (+0.39), MLAB: 112.17 (-1.21), BOXC: 21.80 (+0.17)

CryoLife (CRY) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:05AM CDT
On Jun 11, Zacks Investment Research raised CryoLife Inc. (CRY) to a Zacks Rank #1 (Strong Buy).
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), MLAB: 112.17 (-1.21)

Five Recent Strong Buys In Two Industries
Brian Bolan - Zacks Investment Research - Fri Jun 10, 8:32AM CDT
Five Recent Strong Buys In Two Industries
APLE: 18.74 (-0.20), COR: 79.59 (+0.84), CRY: 16.23 (+0.39), MLAB: 112.17 (-1.21), BOXC: 21.80 (+0.17)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unicycive's Legal Turmoil: Opportunity for Investor Action

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

NORD Honors Innovators Shaping Rare Disease Treatment

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Alex Jones Returns to Austin: New Studio, New Plans

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Wrensilva Unveils Studio Console in White Oak

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Seatrium, Karpowership Wrap Landmark FSRU Partnership

A Milestone in Global Energy Infrastructure Out of Admiralty Yard in Singapore comes a transformation saga that’s begging for attention. Seatrium Limited and Karpowership have pulled off something spectacular with their seventh and final Floating Storage and Regasification Unit (FSRU), LNGT Türkiye. It's not just another vessel hitting the waters—it's the bookend on...

United Apartment Group's Leadership Revamp Signals Growth

A Bold Leadership Expansion Big moves are afoot at United Apartment Group (UAG). They're not just refilling some roles here; they're rebooting their lineup with serious hitters—Woody Stone and Lenzie O’Connor are now steering the ship on business development and client services, eager to drive the company to new heights. Woody Stone: Fueled by Experience Stone isn't...

Miguel Pantoja: Wiring a Second Chance Beyond Bars

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Retirement Security Faces Global Headwinds in 2026

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

BeyondCPG Accelerator Launches Seventh Growth Program

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

illycaffè's B Corp™ Recertification Reflects Bold Commitment

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...